Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt
Overview
– Clinical trials are essential to translate new therapy concepts or rather any intervention into the medical routine. Beside the well designed trial protocol, the success of clinical trials depends on patient recruitment and participation. – This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries.
Full Title of Study: “Knowledge and Perception of Clinical Trial Participation in Breast Cancer Female Patients in Egypt, a Cross Sectional Study”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: December 2020
Interventions
- Behavioral: Knowledge and perception of clinical trial participation
- This study aims to get a current picture of the patients’ knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries
Clinical Trial Outcome Measures
Primary Measures
- The percentage of breast cancer patients who accept to participate in clinical trials
- Time Frame: 1 year
Secondary Measures
- The barriers for participation in clinical trials
- Time Frame: 1 year
Participating in This Clinical Trial
Inclusion Criteria
- Female breast cancer patients Exclusion Criteria:
- Patients who refuse participation
Gender Eligibility: Female
Minimum Age: N/A
Maximum Age: 80 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Ain Shams University
- Provider of Information About this Clinical Study
- Principal Investigator: Hagar Elghazawy, Lecturer of clinical oncology – Ain Shams University
- Overall Official(s)
- Hagar Elghazawy, Principal Investigator, Ain shams university, faculty of medicine
- Overall Contact(s)
- Hagar Elghazawy, MD, 01006232406, dr.hagar.elghazawy@med.asu.edu.eg
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.